MTaPS Country Summary Report: Indonesia (2018-2023)

This report summarizes the MTaPS’ strategic approach, key achievements, and results in Indonesia to strengthen evidence-based decision-making for resource allocation to health technologies and promote transparency in pharmaceutical expenditure (PE) tracking to improve value in purchasing. The report includes recommendations and future considerations for continued implementation of the strengthened health technology assessment (HTA) process and further improvement of the enabling environment for PE tracking in Indonesia.